Clinical Trials Directory

Trials / Unknown

UnknownNCT03937427

Unified Airway Model

Unified Airway Model: Comparison of the Microbiome of the Upper and Lower Airways in Chronic Rhinosinusitis and Asthma Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
24 (estimated)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

Chronic rhinosinusitis (CRS) impacts approximately 5% of Canadians. CRS patients suffer from a combination of symptoms that include facial pain, nasal obstruction, hyposmia and mucopurulence discharge. Asthma may additionally worsen quality of life and many patients suffer from both conditions. The unified airway model illustrates a link between both conditions as tissue from the middle ear to the sinus cavity to the lungs function as one unit. Despite evidence for the unified airway model in the setting of CRS and asthma, there are no studies to our knowledge that have evaluated the microbiome (the resident microbes and their genetic expressions that affect disease) of the upper and lower airways in this patient population. Determining the microbiome of the upper and lower airways in patients suffering from CRS and asthma will further support the unified airway model but more importantly, will help contribute to understanding the pathophysiology of this inflammatory process and may help guide future management.

Conditions

Timeline

Start date
2017-01-16
Primary completion
2019-12-01
Completion
2020-04-01
First posted
2019-05-03
Last updated
2019-05-03

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03937427. Inclusion in this directory is not an endorsement.

Unified Airway Model (NCT03937427) · Clinical Trials Directory